Datwyler to double capacity at its Indian facility
Datwyler is increasing capacity for all three of its production standards in Pune. The expansion will nearly double capacity and add 400 jobs
Datwyler will nearly double capacity at its production operation in Pune, and add 400 jobs in the near future. By starting up a second plant on the premises in the third quarter 2022, the company will increase output significantly to meet growing global demand, according to a company statement.
The statment said that for some time now, Datwyler has been operating all three production standards at its Indian site: Essential, Advanced and FirstLine. Examples for the FirstLine Standard are OmniFlex stoppers for use in vials for global distribution.
FirstLine is the most advanced manufacturing concept in the industry that is specially designed to manufacture pharma rubber components for the high-end pharma and biotech markets. It is designed to meet the highest bar for quality assurance in the production of critical components for pharma packaging. The operation encompasses ultra-modern cleanroom technology, automated production cells, automated camera inspection, and a unique validated washing process, the statement further mentioned.
“We are excited to start up the second plant at our Pune site in these days and proud to significantly expand our capacity,” said Dirk Borghs, Head, Datwyler Healthcare business, in the statement.
The expansion of the Pune facility originally began in 2019, making the original facility Datwyler Healthcare’s largest production operation by volume. Since then, a whole second plant for Essential and Advanced production standard has been added to the campus. This will enable Datwyler to continuously relocate Essential and Advanced production units from the first plant to the new second plant. As a result, there will be free space in the first plant, which will make it possible to expand production capacity for the FirstLine standard, as per the statement.
“The impetus for the expansion at the Pune facility comes from the demand generated for critical pharma packaging components as the injectables market grows rapidly,” said Rahul Dev, Datwyler Senior VP, Global Operations Healthcare Solutions, in the statement.
The entire facility incorporates rational and lean production flows in accordance with the Six Sigma methodology. The FirstLine standard is used to produce Datwyler’s most complex elastomer components. Furthermore, Datwyler’s highly specialised fluoropolymer spray-coated components are manufactured exclusively with this standard and FirstLine is characterised by numerous components to guarantee the highest level of quality and safety, the statement concluded.